HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giyoong Tae Selected Research

Poloxamer (Poloxamer 407)

1/2022All-in-one nanosponge with pluronic shell for synergistic anticancer therapy through effectively overcoming multidrug resistance in cancer.
12/2021Effective and prolonged targeting of a nanocarrier to the inflammation site by functionalization with ZnBPMP and chitosan.
10/2020Temporal Control of Efficient In Vivo Bioconjugation Using a Genetically Encoded Tetrazine-Mediated Inverse-Electron-Demand Diels-Alder Reaction.
1/2020Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E-/- mice.
10/2018Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis.
12/2016The enhanced anti-tissue adhesive effect of injectable pluronic-HA hydrogel by poly(γ-glutamic acid).
7/2015The effect of ligand density on in vivo tumor targeting of nanographene oxide.
10/2013Tumor-targeting nanogel that can function independently for both photodynamic and photothermal therapy and its synergy from the procedure of PDT followed by PTT.
8/2013Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy.
1/2013Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giyoong Tae Research Topics

Disease

18Neoplasms (Cancer)
01/2022 - 05/2010
5Inflammation (Inflammations)
01/2022 - 12/2011
3Wounds and Injuries (Trauma)
02/2021 - 01/2008
2Hypoxia (Hypoxemia)
10/2020 - 01/2020
2Hyperuricemia
10/2020 - 10/2019
2Atherosclerotic Plaque (Atheroma)
01/2020 - 10/2018
2Atherosclerosis
01/2020 - 10/2018
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Hypersensitivity (Allergy)
12/2021
1Ischemia
06/2021
1Type 2 Diabetes Mellitus (MODY)
02/2021
1Neoplasm Metastasis (Metastasis)
01/2020
1Liver Diseases (Liver Disease)
01/2019
1Acute Liver Failure (Fulminant Hepatic Failure)
01/2019
1Hypercalcemia (Milk Alkali Syndrome)
07/2018
1Body Temperature Changes
04/2018
1Tissue Adhesions
12/2016
1Carcinoma (Carcinomatosis)
07/2015
1Cataract (Cataracts)
04/2014
1Brain Diseases (Brain Disorder)
01/2013
1Pain (Aches)
05/2011
1Back Pain (Backache)
05/2011
1Hyperthermia
03/2011
1Corneal Neovascularization
07/2010
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2010
1Foreign Bodies (Foreign Body)
01/2008
1Dehydration (Water Stress)
12/2007

Drug/Important Bio-Agent (IBA)

15Poloxamer (Poloxamer 407)IBA
01/2022 - 05/2010
9ChitosanIBA
12/2021 - 05/2010
4HydrogelsIBA
04/2018 - 12/2007
3Pharmaceutical PreparationsIBA
01/2022 - 02/2015
3Reactive Oxygen Species (Oxygen Radicals)IBA
02/2021 - 01/2019
3Heparin (Liquaemin)FDA LinkGeneric
01/2019 - 05/2010
3GoldIBA
10/2013 - 03/2011
2EnzymesIBA
01/2022 - 10/2019
2CollagenIBA
02/2021 - 10/2018
2Oxygen (Dioxygen)IBA
10/2020 - 01/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2020 - 10/2013
2Urate Oxidase (Uricase)IBA
10/2020 - 10/2019
2Apolipoproteins E (ApoE)IBA
01/2020 - 10/2018
2CytokinesIBA
01/2020 - 01/2019
2LigandsIBA
11/2015 - 07/2015
2OxidesIBA
11/2015 - 07/2015
2Folic Acid (Vitamin M)FDA LinkGeneric
11/2015 - 07/2015
2Photosensitizing Agents (Photosensitizers)IBA
10/2013 - 08/2013
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2022
1cresolIBA
12/2021
1IonsIBA
12/2021
1Therapeutic UsesIBA
06/2021
1Glucagon-Like Peptide 1 (GLP 1)IBA
02/2021
1Peptide Hormones (Polypeptide Hormones)IBA
02/2021
1ferric ferrocyanide (Prussian blue)FDA Link
02/2021
1AntioxidantsIBA
02/2021
1Hemin (Panhematin)FDA Link
10/2020
1Proteins (Proteins, Gene)FDA Link
10/2020
1Interleukin-10 (Interleukin 10)IBA
01/2020
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2020
1CholesterolIBA
01/2020
1LipidsIBA
01/2020
1Uric Acid (Urate)IBA
10/2019
1Peptides (Polypeptides)IBA
10/2018
1ApolipoproteinsIBA
10/2018
1Alendronate (Alendronate Sodium)FDA LinkGeneric
07/2018
1Polymethyl Methacrylate (Sol)IBA
04/2018
1Prostaglandins AIBA
12/2016
1Hyaluronic Acid (Hyaluronan)IBA
12/2016
1Contrast MediaIBA
04/2016
1SolutionsIBA
01/2016
1IntegrinsIBA
11/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2015
1Trastuzumab (Herceptin)FDA Link
02/2015
1Monoclonal AntibodiesIBA
02/2015
1polyethylene glycol polyethyleneimine nanogelIBA
10/2013
1phytochlorinIBA
10/2013
1graphene oxideIBA
08/2013
1Methylene Blue (Methylthioninium Chloride)FDA Link
08/2013
1CY5.5 cyanine dyeIBA
12/2011
1Coloring Agents (Dyes)IBA
12/2011
1Capsaicin (Zostrix)FDA Link
05/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2010
1Polyglactin 910IBA
05/2010
1isothiocyanic acidIBA
03/2010
1SilkFDA Link
03/2010
1GelsIBA
01/2008
1Capsules (Microcapsules)IBA
01/2008

Therapy/Procedure

11Therapeutics
01/2022 - 01/2008
5Photothermal Therapy
11/2015 - 03/2011
4Intravenous Administration
01/2022 - 07/2015
4Intravenous Injections
04/2016 - 03/2011
4Lasers (Laser)
01/2016 - 03/2011
2Phototherapy (Light Therapy)
01/2016 - 08/2013
1Drug Therapy (Chemotherapy)
01/2022
1Photochemotherapy (Photodynamic Therapy)
10/2020
1Injections
12/2016
1Intraocular Lenses (Intraocular Lens)
04/2014
1Precision Medicine
02/2012